The diabetes control and complications trial. Implications for policy and practice.
暂无分享,去创建一个
[1] M. Brownlee,et al. Glycation Products and the Pathogenesis of Diabetic Complications , 1992, Diabetes Care.
[2] T. Orchard,et al. Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective , 1992, Diabetes Care.
[3] S. Genuth. Insulin Use in NIDDM , 1990, Diabetes Care.
[4] UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. , 1991, Diabetologia.
[5] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[6] E. Feldman,et al. Complications: Neuropathy, Pathogenetic Considerations , 1992, Diabetes Care.
[7] P. Reichard,et al. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. , 1993, The New England journal of medicine.
[8] C. Siebert,et al. Survey of Physician Practice Behaviors Related to Diabetes Mellitus in the U.S.: I. Design and Methods , 1993, Diabetes Care.
[9] T. Chalmers,et al. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes , 1993, The Lancet.